The efficacy of anlotinib instead of glucocorticoids for edema induced by brain metastases in NSCLC patients with anti-PD1/PDL-1 immunotherapy

Neuro Oncol. 2021 Jan 30;23(1):169-171. doi: 10.1093/neuonc/noaa236.

Authors

Hongqing Zhuang¹, Yuxia Wang¹, Cheng Cheng¹, Siyu Shi²

Affiliations

¹ Department of Radiation Oncology, Peking University Third Hospital, Beijing, China.
² Stanford University School of Medicine, Stanford, California, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Brain Neoplasms* / drug therapy
Edema
Glucocorticoids
Humans
Immunotherapy
Indoles
Lung Neoplasms* / drug therapy
Quinolines

Substances

Glucocorticoids
Indoles
Quinolines
anlotinib

Associated data

ChiCTR/ChiCTR1800017929
ClinicalTrials.gov/NCT04147728